Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06132-5. Epub ahead of print. PMID: 38584180.